Video Full Description

As an MB&B and economics double major, a Harvard Business School grad, and the COO of Blueprint Medicines (a cutting-edge biotech company working to cure rare diseases), Kate Haviland ’98 has already accomplished so much.

But Kate’s Wesleyan journey, at one critical juncture at least, was defined by failure. While working on an intensive protein synthesis project, she realized she wasn’t very good at lab work. Fortunately, she decided and was encouraged to add an economics major, and that support and exploration led her to where she is today—fulfilled by her family and career, passionate about her work, and making a difference in people’s lives.

Related Videos

  • Wesleyan University 2019 Reunion & Commencement Weekend Highlight...
  • Wes Actually
  • President Roth at the Parents Assembly